Search Results

STEP: A Platform Trial for Stroke Thrombectomy

The rationale and status of the StrokeNet endovascular thrombectomy platform proposal.

By Colin Derdeyn, MD; J Mocco, MD, MS; Tudor G. Jovin, MD; and Caitlyn Meinzer, PhD

Techniques for Cerebral Aneurysm Treatment

Current research aims to expand the tools available for endovascular treatment of this challenging disease.

By Kyle M. Fargen, MD, MPH; Brian L. Hoh, MD; and J Mocco, MD, MS

What's Next in Stroke Care?

Experts discuss the next stages of stroke treatment, focusing on new technologies, systems of care improvements, and clinical trials.

With Johanna T. Fifi, MD; J Mocco, MD, MS; Mahesh V. Jayaraman, MD; Ryan A. McTaggart, MD; and Andrew F. Ducruet, MD

Interventional Stroke Trials: What's Needed, What's Next?

Recent favorable data have added to our stroke management understanding and capabilities but also have presented new key questions to address.

By Reade A. De Leacy, MBBS, and J Mocco, MD, MS

Current Perspective on Self-Expanding Stents for Acute Ischemic Stroke

Experience with this technique and a preview of the first FDA-approved prospective trial, SARIS.

By Elad I. Levy, MD, FACS, FAHA; Sabareesh K. Natarajan, MD, MS; Adnan H. Siddiqui, MD, PhD; Kenneth V. Snyder, MD, PhD; Erik F. Hauck, MD, PhD; J Mocco, MD, MS; and L. Nelson Hopkins, MD, FACS

Maintaining a Robust Acute Stroke Care Network During the COVID-19 Pandemic

A perspective on how a busy health care system in New York City adapted to ensure appropriate stroke care during pandemic conditions.

By Kurt A. Yaeger, MD; Johanna T. Fifi, MD; and J Mocco, MD, MS

Regionalization of Stroke Care: What Can We Learn From Level 1 Trauma Centers?

Rapid triage and transfer of the most critically ill patients to the most skilled physicians is the linchpin to effective regionalization.

By James L. West, MD; Kyle M. Fargen, MD, MPH; and J Mocco, MD, MS

Explorations in Neurointervention

By James Milburn, MD, FACR

Stroke Care Trends During the COVID-19 Pandemic

Three neurointerventionalists share their experiences treating stroke amidst the pandemic, thoughts on why some institutions are seeing a lower incidence of stroke, and a look at the Society for NeuroInterventional Surgery’s public awareness initiative.

With Dorothea Altschul, MD, FAHA; Richard P. Klucznik, MD; and James Milburn, MD, FACR

Chief Medical Editor's Page: Treating Acute Hemorrhagic and Ischemic Stroke

By Lee Guterman, PhD, MD

COVID-19 and Vascular Practices

By John A. Kaufman, MD

Charting a Course: The Future of Neurointervention

By Brian P. Walcott, MD, and William J. Mack, MD

Adding Efficiency to Effectiveness

By Blaise Baxter, MD